615 related articles for article (PubMed ID: 18171210)
41. Predictors and outcomes of linezolid-resistant vancomycin-resistant Enterococcus: a case-case-control study.
Hayakawa K; Marchaim D; Pogue JM; Ho K; Parveen S; Nanjireddy P; Sunkara B; Singla M; Jagadeesh KK; Moshos JA; Bommarito S; Mroue R; Farhat M; Obeid T; Chaudhry A; Vadlamudi G; Lephart PR; Martin ET; Rybak MJ; Kaye KS
Am J Infect Control; 2012 Dec; 40(10):e261-3. PubMed ID: 23199727
[TBL] [Abstract][Full Text] [Related]
42. Varying linezolid susceptibility of vancomycin-resistant Enterococcus faecium isolates during therapy: a case report.
Swoboda S; Fritz S; Martignoni ME; Feldhues RA; Hoppe-Tichy T; Buchler MW; Geiss HK
J Antimicrob Chemother; 2005 Oct; 56(4):787-9. PubMed ID: 16143710
[TBL] [Abstract][Full Text] [Related]
43. Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia.
Garbutt JM; Ventrapragada M; Littenberg B; Mundy LM
Clin Infect Dis; 2000 Mar; 30(3):466-72. PubMed ID: 10722429
[TBL] [Abstract][Full Text] [Related]
44. Treatment of prosthetic valve infective endocarditis due to multi-resistant Gram-positive bacteria with linezolid.
Wareham DW; Abbas H; Karcher AM; Das SS
J Infect; 2006 Apr; 52(4):300-4. PubMed ID: 16099052
[TBL] [Abstract][Full Text] [Related]
45. Treatment of vancomycin-resistant enterococcal infections in the immunocompromised host: quinupristin-dalfopristin in combination with minocycline.
Raad I; Hachem R; Hanna H; Girgawy E; Rolston K; Whimbey E; Husni R; Bodey G
Antimicrob Agents Chemother; 2001 Nov; 45(11):3202-4. PubMed ID: 11600379
[TBL] [Abstract][Full Text] [Related]
46. Treatment of life-threatening multiresistant staphylococcal and enterococcal infections in patients with end-stage renal failure with quinupristin/dalfopristin: preliminary report.
Schwenger V; Mündlein E; Dagrosa EE; Fahr AM; Zeier M; Mikus G; Andrassy K
Infection; 2002 Oct; 30(5):257-61. PubMed ID: 12382082
[TBL] [Abstract][Full Text] [Related]
47. Differences in clinical outcomes in patients with vancomycin-resistant enterococci according to linezolid susceptibility.
Scheetz MH; Knechtel SA; Postelnick MJ; Malczynski M; Qi C
Pharmacotherapy; 2010 Dec; 30(12):1221-8. PubMed ID: 21114389
[TBL] [Abstract][Full Text] [Related]
48. Antimicrobial activity of mupirocin, daptomycin, linezolid, quinupristin/dalfopristin and tigecycline against vancomycin-resistant enterococci (VRE) from clinical isolates in Korea (1998 and 2005).
Lee DK; Kim Y; Park KS; Yang JW; Kim K; Ha NJ
J Biochem Mol Biol; 2007 Nov; 40(6):881-7. PubMed ID: 18047782
[TBL] [Abstract][Full Text] [Related]
49. Vancomycin-resistant enterococcal urinary tract infections.
Heintz BH; Halilovic J; Christensen CL
Pharmacotherapy; 2010 Nov; 30(11):1136-49. PubMed ID: 20973687
[TBL] [Abstract][Full Text] [Related]
50. Risk factors and outcomes associated with vancomycin-resistant Enterococcus infections with reduced susceptibilities to linezolid.
Santayana EM; Grim SA; Janda WM; Layden JE; Lee TA; Clark NM
Diagn Microbiol Infect Dis; 2012 Sep; 74(1):39-42. PubMed ID: 22749382
[TBL] [Abstract][Full Text] [Related]
51. Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.
Florescu I; Beuran M; Dimov R; Razbadauskas A; Bochan M; Fichev G; Dukart G; Babinchak T; Cooper CA; Ellis-Grosse EJ; Dartois N; Gandjini H;
J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i17-28. PubMed ID: 18684703
[TBL] [Abstract][Full Text] [Related]
52. Treatment of multifocal vancomycin-resistant Enterococcus faecium osteomyelitis in sickle cell disease: a preliminary report.
Bibbo C; Patel DV; Tyndall WA; Sirkin MS; Chang V
Am J Orthop (Belle Mead NJ); 2003 Oct; 32(10):505-9. PubMed ID: 14620092
[TBL] [Abstract][Full Text] [Related]
53. Consequences of vancomycin-resistant Enterococcus in liver transplant recipients: a matched control study.
Gearhart M; Martin J; Rudich S; Thomas M; Wetzel D; Solomkin J; Hanaway MJ; Aranda-Michel J; Weber F; Trumball L; Bass M; Zavala E; Steve Woodle E; Buell JF
Clin Transplant; 2005 Dec; 19(6):711-6. PubMed ID: 16313314
[TBL] [Abstract][Full Text] [Related]
54. Bacteremia caused by an Enterococcus faecalis isolate with high-level linezolid resistance in a teenager with Crohn's disease.
Lopez Marti MG; Jhaveri R
Pediatr Infect Dis J; 2009 Jul; 28(7):663-4. PubMed ID: 19451857
[TBL] [Abstract][Full Text] [Related]
55. Antibiotics for gram-positive bacterial infections: vancomycin, quinupristin-dalfopristin, linezolid, and daptomycin.
Lundstrom TS; Sobel JD
Infect Dis Clin North Am; 2004 Sep; 18(3):651-68, x. PubMed ID: 15308280
[TBL] [Abstract][Full Text] [Related]
56. Clinical-use-associated decrease in susceptibility of vancomycin-resistant Enterococcus faecium to linezolid: a comparison with quinupristin-dalfopristin.
Raad II; Hanna HA; Hachem RY; Dvorak T; Arbuckle RB; Chaiban G; Rice LB
Antimicrob Agents Chemother; 2004 Sep; 48(9):3583-5. PubMed ID: 15328133
[TBL] [Abstract][Full Text] [Related]
57. Use of linezolid in children: an overview of recent advances.
Velissariou IM
Expert Rev Anti Infect Ther; 2006 Dec; 4(6):947-52. PubMed ID: 17181410
[TBL] [Abstract][Full Text] [Related]
58. [Our experience with linesolid usage in newborn children].
Atanasova V; Slavkova N; Rosmanova R
Akush Ginekol (Sofiia); 2007; 46 Suppl 1():60-2. PubMed ID: 18173016
[TBL] [Abstract][Full Text] [Related]
59. Observational study of the epidemiology and outcomes of vancomycin-resistant Enterococcus bacteraemia treated with newer antimicrobial agents.
McKinnell JA; Patel M; Shirley RM; Kunz DF; Moser SA; Baddley JW
Epidemiol Infect; 2011 Sep; 139(9):1342-50. PubMed ID: 21073764
[TBL] [Abstract][Full Text] [Related]
60. Emergence of resistance to chloramphenicol among vancomycin-resistant enterococcal (VRE) bloodstream isolates.
Lautenbach E; Gould CV; LaRosa LA; Marr AM; Nachamkin I; Bilker WB; Fishman NO
Int J Antimicrob Agents; 2004 Feb; 23(2):200-3. PubMed ID: 15013047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
